Phase III results show brexpiprazole to be well tolerated as adjunctive therapy for MDD patients March 7, 2014
Longer-acting clotting factor FVIIa-CTP shows promise, obtains FDA orphan drug designation March 5, 2014
Northern Manhattan Study links markers of infection and neuroendocrine dysfunction with stroke risk March 5, 2014
RSS